Mumbai, Feb 4 (NVI) Alkem Laboratories Ltd today announced the launch of Kojiglo serum in India for managing facial hyperpigmentation.
Alkem said it is the first Indian company to introduce a liposomal serum with Duo-Lipo technology. The serum is suitable for all skin types.
Kojiglo serum will be available on prescription and hence it will be necessary to consult a dermatologist before using the product.
This innovative formulation combines cutting-edge ingredients such as liposomal azelaic
acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide, making it
a first of its kind in India to have a Duo-Lipo technology, it said in a statement.
This advanced serum encapsulates the active ingredients in a liposomal form to enhance penetration in the skin and deliver targeted action and the formulation ensures effective results while reducing the risk of skin sensitivity and irritation, the company said.
The active pharmaceutical ingredients are carefully sourced to meet global quality standards, offering a high-quality, reliable solution for facial hyperpigmentation.
Dr. Vikas Gupta, Chief Executive Officer of Alkem, said, “The prevalence of skin
hyperpigmentation among Indian population is quite high and awareness about managing
this condition is gradually increasing. We are pleased to introduce an advanced serum
designed to effectively address hyperpigmentation concerns.”
Alkem has its presence in the demelanising category with products like Kojiglo cream,
Kojiglo face wash and Kojiglo lotion.
With the introduction of Kojiglo serum, Alkem aims to broaden its portfolio and increase its
market share in the skincare segment.
